Key Takeaways
- Shares of Palantir closed at $131.94 on Tuesday, declining 2% and extending year-to-date losses to 26%, with the stock now 36% below its November 2025 peak of $207.18.
- Wolfe Research lifted its rating on PLTR to Peer Perform from Underperform, though analysts refrained from setting a specific price target.
- Analysts at Wolfe characterized Palantir as “the most applied enterprise AI software company” while simultaneously noting its status as “the most expensive in software.”
- UBS continues to rate the stock as Buy with a $200 target, acknowledging investor worries regarding competitive pressure from OpenAI, Anthropic, and Databricks.
- Among 32 Wall Street analysts monitored by FactSet, the consensus rating stands at Overweight with an average price target of $189.87, suggesting 44% potential upside.
A Tuesday upgrade from Wolfe Research couldn’t prevent Palantir Technologies (PLTR) from sliding 2%.
The market’s reaction speaks volumes about current sentiment surrounding the stock.
Palantir Technologies Inc., PLTR
Shares closed at $131.94, continuing a challenging period that has erased 26% of the stock’s value in 2026. June alone has witnessed a 16% decline, leaving PLTR trading 36% beneath its all-time closing high of $207.18 reached on November 3, 2025.
Meanwhile, the broader S&P 500 has climbed 10% year to date, while the Nasdaq Composite has advanced approximately 14%.
Analysts Alex Zukin and Joshua Tilton at Wolfe Research reinstated coverage of PLTR with a Peer Perform designation, an improvement from their previous Underperform stance. The firm opted not to include a specific price objective with this recommendation.
Their assessment presents a balanced perspective. While they recognize Palantir as the preeminent applied enterprise AI software provider with industry-leading growth metrics, they maintain that the stock’s present valuation “is still the most expensive in software.”
PLTR currently commands a forward price-to-earnings multiple of approximately 77.4x, substantially above the S&P 500’s 21.07x ratio.
“We love the business,” Zukin stated, “and if growth trends closer to our upside scenario we could find ourselves looking at an entry point too good to ignore.” However, the firm believes the current valuation already reflects much of the anticipated growth acceleration and margin expansion.
The Ontology Advantage
Wolfe’s research team highlighted Palantir’s Ontology platform as its critical competitive advantage. This proprietary database infrastructure bridges AI capabilities with human decision-making to streamline enterprise operations. Zukin observed that Ontology sales momentum and backlog growth are strengthening in 2026, which he views as an encouraging indicator.
Earlier on Tuesday, UBS analyst Karl Keirstead maintained his Buy recommendation with a $200 price objective. Keirstead held firm on his outlook following discussions with Palantir’s management team that centered largely on competitive dynamics.
Competitive Landscape Under Scrutiny
The primary concern raised by investors during the UBS meeting centered on whether competitors such as OpenAI, Anthropic, and Databricks — all developing field deployment capabilities and data context infrastructure — might threaten Palantir’s ontology advantage.
Palantir’s management countered these concerns, emphasizing that its operating platform extends far beyond simple large language model deployment or data ingestion. The company expressed skepticism about large language model providers successfully penetrating the data infrastructure layer.
With a gross profit margin of 84%, Palantir demonstrates significant pricing leverage and competitive strength, according to UBS analysis.
InvestingPro data indicates that 21 analysts have recently increased their earnings projections.
Additional recent analyst activity includes Rosenblatt maintaining its Buy rating following new customer acquisitions and a Google Cloud collaboration unveiled at AIPCon 10. Baird similarly held its Outperform rating with a $200 target following its own management discussions.
The UK government has announced plans to review Palantir’s agreement with the National Health Service.
Across 32 firms monitored by FactSet, PLTR holds an average Overweight recommendation with a median price target of $189.87, implying 44% upside potential from present levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
